Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06540547 · ClinicalTrials.gov registry record · NA

Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study

A NA study of ADHD and Parenting, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06540547: Recruiting NA study of ADHD and Parenting, sponsored by University of Pittsburgh.

NCT06540547 is a NA study of ADHD and Parenting that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06540547, a NA study of ADHD and Parenting, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in OB care settings.

Primary Outcome

Therapist and participant report of intervention acceptability will be assessed using the 4-item Acceptability of Intervention Measure (AIM), rated from rated from 1 (completely disagree) to 5 (completely agree), with scores greater than or equal to 16 indicating good acceptability.

Conditions Studied

Interventions

  • BEHAVIORAL MomMA Intervention

Study Locations (1)

Pennsylvania

  • UPMC Magee Women's Hospital - Pittsburgh

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-01-19
Est. Completion 2026-07-31
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06540547 shows while recruiting

NCT06540547 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 190-participant average among 75 other ADHD trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which MomMA Intervention is the first listed.

NCT06540547 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06540547 about?

NCT06540547 is a clinical study titled "Moms Managing Attention-Deficit/Hyperactivity Disorder (ADHD) Study". The study will develop and test a behavioral program for pregnant individuals with Attention-Deficit/Hyperactivity Disorder (ADHD). This behavioral program will include skills for managing ADHD and related symptoms during pregnancy and after delivery and will be taught by a behavioral therapist in O...

What is the current status of trial NCT06540547?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-01-19. Estimated completion is 2026-07-31.

What conditions does trial NCT06540547 study?

This clinical trial studies the following conditions: ADHD, Parenting.

What interventions are being tested in trial NCT06540547?

The interventions under investigation include: MomMA Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06540547?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06540547 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06540547's enrollment target sits among peer trials

10 73rd of 75 higher than 3 of 75 other ADHD trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other ADHD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06540547, the US trial registry maintained by the National Library of Medicine. NCT06540547 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.